Treatment of chronic myeloid leukemia (CML) has changed drastically with the emergence of the Abl tyrosine kinase inhibitor (TKI), imatinib mesylate. However, primary and secondary resistance have ...
While Bryan was making his observations with the CD8–ζ chain chimera, a very talented group of postdoctoral fellows in my laboratory were on the hunt for a TCR-associated tyrosine kinase that ...